Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TER vs GSK✓SelectedUSD · GSKTER vs GSK performance historyLatest closeAs of-9.96%11/20
Stock and ETF performance explorer

TER vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+773.5%
GSK return
+97.4%
Excess return
+676.0%
Maximum drawdown
-59.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-10.0%-0.1%-9.8%-9.9%
7D-17.9%-5.3%-12.6%-16.2%
30D-40.7%-3.7%-37.1%-40.0%
3M-46.5%-7.3%-39.3%-45.4%
6M-40.5%-4.2%-36.2%-41.0%
YTD+5.9%+0.9%+5.1%+3.1%
1Y+31.6%+7.3%+24.3%+24.6%
3Y+122.4%+52.7%+69.7%+74.4%
5Y+38.0%+40.1%-2.1%+9.2%
All+773.5%+97.4%+676.0%+486.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling